Medpace Holdings
Price
Price
CHART BY
Frequently asked questions
What is Medpace Holdings's market capitalization?
What is Medpace Holdings's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Medpace Holdings?
What are the analyst ratings and target price for Medpace Holdings's stock?
What is Medpace Holdings's revenue over the trailing twelve months?
What is the EBITDA for Medpace Holdings?
What is the free cash flow of Medpace Holdings?
How many employees does Medpace Holdings have, and what sector and industry does it belong to?
What is the free float of Medpace Holdings's shares?
Financials
- Market Cap
- $10.37B
- EPS (TTM)
- $12.63
- Free Float
- 24.99M
- P/E ratio (TTM)
- 26.94
- Revenue (TTM)
- $2.11B
- EBITDA (TTM)
- $476.12M
- Free Cashflow (TTM)
- $572.27M
Pricing
- 1D span
- $339.64$347.72
- 52W span
- $302.01$457.94
Analyst Ratings
The price target is $354.38 and the stock is covered by 12 analysts.
Buy
4
Hold
7
Sell
1
Information
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
- Employees
- 5,900
- Industries
- Miscellaneous Commercial Services
- Sector
- Health Care
Identifier
- ISIN
- US58506Q1094
- Primary Ticker
- MEDP